Tapewire

NYSE · USD

THC

TENET HEALTHCARE CORP

Export transactions ↓
Tapewire entity
2563
SEC CIK
0000070318
Parsed reports
494

Last 12 months

Inside the activity.

0 purchase rows · 42 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202509
Dec 202501
Jan 202600
Feb 202600
Mar 202607
Apr 202600
May 202606
Jun 202600
Jul 202604
Aug 2026010
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2019 Filed Mar 1, 2019 22:43 UTC
Andrews Audrey T.SVP and General Counsel
Grant2019 February Performance Stock Options (Right to Buy) · Derivative 40,033 $0.00 Strike: $28.26 $0.00
Disclosure

SEC source: 0001209191-19-015134 · doc4.xml · derivative · entry 2

Andrews Audrey T. · CIK 0001568933 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,033

Underlying: Common Stock · 40,033 shares

Expires 2029-02-27

F2 · derivative.exercise_date: These performance-based stock options vest on the third anniversary of the date of grant, subject to the satisfaction of a stock price performance condition requiring the Company's common stock price to close at or above $35.33 per share for any 20 consecutive trading days during the three-year period following the date of grant.

Read SEC document
February 27, 2019 Filed Mar 1, 2019 22:43 UTC
Andrews Audrey T.SVP and General Counsel
Grant2019 February Restricted Stock Units · Derivative 17,693 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-015134 · doc4.xml · derivative · entry 1

Andrews Audrey T. · CIK 0001568933 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,693

Underlying: Common Stock · 17,693 shares

Expires not disclosed

F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.

F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.

F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
February 26, 2019 Filed Feb 28, 2019 22:44 UTC
Ramsey R. ScottPrincipal Accounting Officer
Exercise / conversion2014 February Restricted Stock Units · Derivative 2,255 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-014650 · doc4.xml · derivative · entry 3

Ramsey R. Scott · CIK 0001558231 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,255 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F1 · derivative.exercise_date: As previously reported, on February 26, 2014, the reporting person received a grant of 2,255 time-based restricted stock units that vest in their entirety on the fifth anniversary of the date of grant. The fifth anniversary occurred on February 26, 2019, resulting in the vesting and settlement of 2,255 shares of common stock, as shown in Table I.

F1 · derivative.expiration_date: As previously reported, on February 26, 2014, the reporting person received a grant of 2,255 time-based restricted stock units that vest in their entirety on the fifth anniversary of the date of grant. The fifth anniversary occurred on February 26, 2019, resulting in the vesting and settlement of 2,255 shares of common stock, as shown in Table I.

F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
February 26, 2019 Filed Feb 28, 2019 22:44 UTC
Ramsey R. ScottPrincipal Accounting Officer
Tax withholdingCommon Stock 669 $26.94 $18,022.86
Disclosure

SEC source: 0001209191-19-014650 · doc4.xml · nonDerivative · entry 2

Ramsey R. Scott · CIK 0001558231 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,388

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
February 26, 2019 Filed Feb 28, 2019 22:44 UTC
Ramsey R. ScottPrincipal Accounting Officer
Exercise / conversionCommon Stock 2,255 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-014650 · doc4.xml · nonDerivative · entry 1

Ramsey R. Scott · CIK 0001558231 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously reported, on February 26, 2014, the reporting person received a grant of 2,255 time-based restricted stock units that vest in their entirety on the fifth anniversary of the date of grant. The fifth anniversary occurred on February 26, 2019, resulting in the vesting and settlement of 2,255 shares of common stock, as shown in Table I.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 31, 2019 Filed Feb 5, 2019 00:22 UTC
Sutaria SaumyaChief Operating Officer
Grant2019 January Restricted Stock Units · Derivative 318,327 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-007115 · doc4.xml · derivative · entry 1

Sutaria Saumya · CIK 0001760857 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,327

Underlying: Common Stock · 318,327 shares

Expires not disclosed

F1 · derivative.exercise_price: These time-based restricted stock units will vest on January 6, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting.

F1 · derivative.exercise_date: These time-based restricted stock units will vest on January 6, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting.

F1 · derivative.expiration_date: These time-based restricted stock units will vest on January 6, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
November 30, 2018 Filed Dec 3, 2018 22:15 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversion2018 June Restricted Stock Units · Derivative 7,306 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-060599 · doc4.xml · derivative · entry 7

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,534

Underlying: Common Stock · 7,306 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The second vesting date occurred on November 30, 2018 (the business day prior to December 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 36,534 restricted stock units are shown in Table II.

F4 · derivative.exercise_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The second vesting date occurred on November 30, 2018 (the business day prior to December 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 36,534 restricted stock units are shown in Table II.

F4 · derivative.expiration_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The second vesting date occurred on November 30, 2018 (the business day prior to December 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 36,534 restricted stock units are shown in Table II.

F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
November 30, 2018 Filed Dec 3, 2018 22:15 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversion2018 March Restricted Stock Units · Derivative 36,082 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-060599 · doc4.xml · derivative · entry 6

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,414

Underlying: Common Stock · 36,082 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on November 30, 2018 (the business day prior to December 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 180,414 restricted stock units are shown in Table II.

F1 · derivative.exercise_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on November 30, 2018 (the business day prior to December 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 180,414 restricted stock units are shown in Table II.

F1 · derivative.expiration_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on November 30, 2018 (the business day prior to December 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 180,414 restricted stock units are shown in Table II.

F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
November 30, 2018 Filed Dec 3, 2018 22:15 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Tax withholdingCommon Stock 2,875 $26.07 $74,951.25
Disclosure

SEC source: 0001209191-18-060599 · doc4.xml · nonDerivative · entry 4

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,435

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
November 30, 2018 Filed Dec 3, 2018 22:15 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversionCommon Stock 7,306 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-060599 · doc4.xml · nonDerivative · entry 3

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,310

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The second vesting date occurred on November 30, 2018 (the business day prior to December 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 36,534 restricted stock units are shown in Table II.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
November 30, 2018 Filed Dec 3, 2018 22:15 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Tax withholdingCommon Stock 14,199 $26.07 $370,167.93
Disclosure

SEC source: 0001209191-18-060599 · doc4.xml · nonDerivative · entry 2

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,004

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
November 30, 2018 Filed Dec 3, 2018 22:15 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversionCommon Stock 36,082 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-060599 · doc4.xml · nonDerivative · entry 1

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,203

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on November 30, 2018 (the business day prior to December 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 180,414 restricted stock units are shown in Table II.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
August 31, 2018 Filed Sep 4, 2018 21:09 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversion2018 June Restricted Stock Units · Derivative 7,306 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-049252 · doc4.xml · derivative · entry 7

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,840

Underlying: Common Stock · 7,306 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The first vesting date occurred on August 31, 2018 (the business day prior to September 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 43,840 restricted stock units are shown in Table II.

F4 · derivative.exercise_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The first vesting date occurred on August 31, 2018 (the business day prior to September 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 43,840 restricted stock units are shown in Table II.

F4 · derivative.expiration_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The first vesting date occurred on August 31, 2018 (the business day prior to September 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 43,840 restricted stock units are shown in Table II.

F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
August 31, 2018 Filed Sep 4, 2018 21:09 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversion2018 March Restricted Stock Units · Derivative 36,082 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-049252 · doc4.xml · derivative · entry 6

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,496

Underlying: Common Stock · 36,082 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The second vesting date occurred on August 31, 2018 (the business day prior to September 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 216,496 restricted stock units are shown in Table II.

F1 · derivative.exercise_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The second vesting date occurred on August 31, 2018 (the business day prior to September 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 216,496 restricted stock units are shown in Table II.

F1 · derivative.expiration_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The second vesting date occurred on August 31, 2018 (the business day prior to September 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 216,496 restricted stock units are shown in Table II.

F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
August 31, 2018 Filed Sep 4, 2018 21:09 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Tax withholdingCommon Stock 2,875 $33.72 $96,945.00
Disclosure

SEC source: 0001209191-18-049252 · doc4.xml · nonDerivative · entry 4

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,121

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
August 31, 2018 Filed Sep 4, 2018 21:09 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversionCommon Stock 7,306 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-049252 · doc4.xml · nonDerivative · entry 3

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,996

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The first vesting date occurred on August 31, 2018 (the business day prior to September 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 43,840 restricted stock units are shown in Table II.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
August 31, 2018 Filed Sep 4, 2018 21:09 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Tax withholdingCommon Stock 14,199 $33.72 $478,790.28
Disclosure

SEC source: 0001209191-18-049252 · doc4.xml · nonDerivative · entry 2

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,690

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
August 31, 2018 Filed Sep 4, 2018 21:09 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversionCommon Stock 36,082 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-049252 · doc4.xml · nonDerivative · entry 1

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The second vesting date occurred on August 31, 2018 (the business day prior to September 1, 2018, which fell on a weekend), resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 216,496 restricted stock units are shown in Table II.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
June 29, 2018 Filed Jun 29, 2018 20:32 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Grant2018 June Restricted Stock Units · Derivative 51,146 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-040036 · doc4.xml · derivative · entry 1

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,146

Underlying: Common Stock · 51,146 shares

Expires not disclosed

F1 · derivative.exercise_price: These time-based restricted stock units vest and settle in seven equal quarterly installments on the following dates: September 1, 2018; December 1, 2018; March 1, 2019; June 1, 2019; September 1, 2019; December 1, 2019; and February 28, 2020. Restricted stock units are settled in shares of the Company's common stock upon vesting.

F1 · derivative.exercise_date: These time-based restricted stock units vest and settle in seven equal quarterly installments on the following dates: September 1, 2018; December 1, 2018; March 1, 2019; June 1, 2019; September 1, 2019; December 1, 2019; and February 28, 2020. Restricted stock units are settled in shares of the Company's common stock upon vesting.

F1 · derivative.expiration_date: These time-based restricted stock units vest and settle in seven equal quarterly installments on the following dates: September 1, 2018; December 1, 2018; March 1, 2019; June 1, 2019; September 1, 2019; December 1, 2019; and February 28, 2020. Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
June 01, 2018 Filed Jun 4, 2018 22:51 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversion2018 March Restricted Stock Units · Derivative 36,082 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-035352 · doc4.xml · derivative · entry 4

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 252,578

Underlying: Common Stock · 36,082 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The first vesting date occurred on June 1, 2018, resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 252,578 restricted stock units are shown in Table II.

F1 · derivative.exercise_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The first vesting date occurred on June 1, 2018, resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 252,578 restricted stock units are shown in Table II.

F1 · derivative.expiration_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The first vesting date occurred on June 1, 2018, resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 252,578 restricted stock units are shown in Table II.

F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
June 01, 2018 Filed Jun 4, 2018 22:51 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Tax withholdingCommon Stock 13,430 $35.23 $473,138.90
Disclosure

SEC source: 0001209191-18-035352 · doc4.xml · nonDerivative · entry 2

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,807

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
June 01, 2018 Filed Jun 4, 2018 22:51 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Exercise / conversionCommon Stock 36,082 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-035352 · doc4.xml · nonDerivative · entry 1

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,237

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The first vesting date occurred on June 1, 2018, resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 252,578 restricted stock units are shown in Table II.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
May 31, 2018 Filed Jun 4, 2018 22:46 UTC GrantCommon Stock 7,912 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-035345 · doc4.xml · nonDerivative · entry 1

Fitzgerald Meghan · CIK 0001349297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,912

F1 · security: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 1,835 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 6,077 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 1,835 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 6,077 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
May 31, 2018 Filed Jun 4, 2018 22:30 UTC GrantCommon Stock 7,912 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-035322 · doc4.xml · nonDerivative · entry 1

Austin Lloyd J. III · CIK 0001680876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,912

F1 · security: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 1,835 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 6,077 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 1,835 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 6,077 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
May 04, 2018 Filed May 8, 2018 20:59 UTC
Romo TammyDirector
GrantCommon Stock 7,439 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-028630 · doc4.xml · nonDerivative · entry 1

Romo Tammy · CIK 0001558014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,846

F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
May 04, 2018 Filed May 8, 2018 20:57 UTC GrantCommon Stock 7,439 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-028624 · doc4.xml · nonDerivative · entry 1

MARK RICHARD J · CIK 0001190100 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,869

F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
May 04, 2018 Filed May 8, 2018 20:55 UTC GrantCommon Stock 9,564 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-028617 · doc4.xml · nonDerivative · entry 1

KERREY J ROBERT · CIK 0001179100 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,200

F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
May 04, 2018 Filed May 8, 2018 20:52 UTC
KANGAS EDWARD ADirector · Chairman
GrantCommon Stock 7,439 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-028612 · doc4.xml · nonDerivative · entry 1

KANGAS EDWARD A · CIK 0001211047 · Director · Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,321

F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
May 04, 2018 Filed May 8, 2018 20:50 UTC GrantCommon Stock 7,439 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-028607 · doc4.xml · nonDerivative · entry 1

GAINES BRENDA J · CIK 0001204074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,116

F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
May 04, 2018 Filed May 8, 2018 20:48 UTC GrantCommon Stock 7,439 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-028603 · doc4.xml · nonDerivative · entry 1

FISHER RICHARD W · CIK 0001287510 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,869

F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
May 04, 2018 Filed May 8, 2018 20:45 UTC GrantCommon Stock 7,439 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-028599 · doc4.xml · nonDerivative · entry 1

BIERMAN JAMES L · CIK 0001189534 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,286

F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected).

Read SEC document
April 30, 2018 Filed May 1, 2018 23:37 UTC
Evans Jason EricPres. of Hospital Operations
Exercise / conversion2015 April Performance-Based Restricted Stock Units · Derivative 1,434 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-027206 · doc4.xml · derivative · entry 6

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: As previously reported, on 4/30/15, the reporting person received a target grant of 2,612 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending 12/31/15. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded & 164.7% of the target grant was awarded; therefore, these restricted stock units vest in 1/3 increments on each of the 1st, 2nd & 3rd anniversaries of the date of grant. The 1st vesting date occurred on 4/29/16, resulting in the vesting & settlement of 1,433 shares of common stock. The 2nd vesting date occurred on 4/28/17, resulting in the vesting & settlement of 1,435 shares of common stock. The 3rd vesting date occurred on 4/30/18, resulting in the vesting & settlement of 1,434 shares of common stock, as shown in Table I.

F4 · derivative.exercise_date: As previously reported, on 4/30/15, the reporting person received a target grant of 2,612 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending 12/31/15. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded & 164.7% of the target grant was awarded; therefore, these restricted stock units vest in 1/3 increments on each of the 1st, 2nd & 3rd anniversaries of the date of grant. The 1st vesting date occurred on 4/29/16, resulting in the vesting & settlement of 1,433 shares of common stock. The 2nd vesting date occurred on 4/28/17, resulting in the vesting & settlement of 1,435 shares of common stock. The 3rd vesting date occurred on 4/30/18, resulting in the vesting & settlement of 1,434 shares of common stock, as shown in Table I.

F4 · derivative.expiration_date: As previously reported, on 4/30/15, the reporting person received a target grant of 2,612 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending 12/31/15. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded & 164.7% of the target grant was awarded; therefore, these restricted stock units vest in 1/3 increments on each of the 1st, 2nd & 3rd anniversaries of the date of grant. The 1st vesting date occurred on 4/29/16, resulting in the vesting & settlement of 1,433 shares of common stock. The 2nd vesting date occurred on 4/28/17, resulting in the vesting & settlement of 1,435 shares of common stock. The 3rd vesting date occurred on 4/30/18, resulting in the vesting & settlement of 1,434 shares of common stock, as shown in Table I.

F5 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
April 30, 2018 Filed May 1, 2018 23:37 UTC
Evans Jason EricPres. of Hospital Operations
Exercise / conversion2015 April Restricted Stock Units · Derivative 871 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-027206 · doc4.xml · derivative · entry 5

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 871 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As previously reported, on 4/30/15, the reporting person received a grant of 2,612 time-based RSUs that vest in 1/3 increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st vesting date occurred on 4/29/16 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 870 shares of common stock. The 2nd vesting date occurred on 4/28/17 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 871 shares of common stock. The 3rd vesting date occurred on 4/30/18, resulting in the vesting and settlement of 871 shares of common stock, as shown in Table I.

F1 · derivative.exercise_date: As previously reported, on 4/30/15, the reporting person received a grant of 2,612 time-based RSUs that vest in 1/3 increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st vesting date occurred on 4/29/16 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 870 shares of common stock. The 2nd vesting date occurred on 4/28/17 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 871 shares of common stock. The 3rd vesting date occurred on 4/30/18, resulting in the vesting and settlement of 871 shares of common stock, as shown in Table I.

F1 · derivative.expiration_date: As previously reported, on 4/30/15, the reporting person received a grant of 2,612 time-based RSUs that vest in 1/3 increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st vesting date occurred on 4/29/16 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 870 shares of common stock. The 2nd vesting date occurred on 4/28/17 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 871 shares of common stock. The 3rd vesting date occurred on 4/30/18, resulting in the vesting and settlement of 871 shares of common stock, as shown in Table I.

F5 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
April 30, 2018 Filed May 1, 2018 23:37 UTC
Evans Jason EricPres. of Hospital Operations
Tax withholdingCommon Stock 565 $23.94 $13,526.10
Disclosure

SEC source: 0001209191-18-027206 · doc4.xml · nonDerivative · entry 4

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,206

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
April 30, 2018 Filed May 1, 2018 23:37 UTC
Evans Jason EricPres. of Hospital Operations
Exercise / conversionCommon Stock 1,434 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-027206 · doc4.xml · nonDerivative · entry 3

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: As previously reported, on 4/30/15, the reporting person received a target grant of 2,612 performance-based RSUs that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending 12/31/15. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded & 164.7% of the target grant was awarded; therefore, these restricted stock units vest in 1/3 increments on each of the 1st, 2nd & 3rd anniversaries of the date of grant. The 1st vesting date occurred on 4/29/16, resulting in the vesting & settlement of 1,433 shares of common stock. The 2nd vesting date occurred on 4/28/17, resulting in the vesting & settlement of 1,435 shares of common stock. The 3rd vesting date occurred on 4/30/18, resulting in the vesting & settlement of 1,434 shares of common stock, as shown in Table I.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
April 30, 2018 Filed May 1, 2018 23:37 UTC
Evans Jason EricPres. of Hospital Operations
Tax withholdingCommon Stock 343 $23.94 $8,211.42
Disclosure

SEC source: 0001209191-18-027206 · doc4.xml · nonDerivative · entry 2

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,337

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
April 30, 2018 Filed May 1, 2018 23:37 UTC
Evans Jason EricPres. of Hospital Operations
Exercise / conversionCommon Stock 871 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-027206 · doc4.xml · nonDerivative · entry 1

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously reported, on 4/30/15, the reporting person received a grant of 2,612 time-based RSUs that vest in 1/3 increments on each of the 1st, 2nd and 3rd anniversaries of the date of grant. The 1st vesting date occurred on 4/29/16 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 870 shares of common stock. The 2nd vesting date occurred on 4/28/17 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 871 shares of common stock. The 3rd vesting date occurred on 4/30/18, resulting in the vesting and settlement of 871 shares of common stock, as shown in Table I.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 21:33 UTC
Rittenmeyer Ronald ADirector · Executive Chairman and CEO
Grant2018 March Restricted Stock Units · Derivative 288,660 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022538 · doc4.xml · derivative · entry 1

Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,660

Underlying: Common Stock · 288,660 shares

Expires not disclosed

F1 · derivative.exercise_price: These time-based restricted stock units vest and settle in eight equal quarterly installments on the following dates: June 1, 2018; September 1, 2018; December 1, 2018; March 1, 2019; June 1, 2019; September 1, 2019; December 1, 2019; and February 28, 2020. Restricted stock units are settled in shares of the Company's common stock upon vesting.

F1 · derivative.exercise_date: These time-based restricted stock units vest and settle in eight equal quarterly installments on the following dates: June 1, 2018; September 1, 2018; December 1, 2018; March 1, 2019; June 1, 2019; September 1, 2019; December 1, 2019; and February 28, 2020. Restricted stock units are settled in shares of the Company's common stock upon vesting.

F1 · derivative.expiration_date: These time-based restricted stock units vest and settle in eight equal quarterly installments on the following dates: June 1, 2018; September 1, 2018; December 1, 2018; March 1, 2019; June 1, 2019; September 1, 2019; December 1, 2019; and February 28, 2020. Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 21:30 UTC
Evans Jason EricPres. of Hospital Operations
Exercise / conversion2016 March Restricted Stock Units · Derivative 5,761 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-022531 · doc4.xml · derivative · entry 3

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,762

Underlying: Common Stock · 5,761 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On March 31, 2016, the reporting person received a grant of 17,284 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 31, 2017, resulting in the vesting and settlement of 5,761 shares of common stock. The second vesting date occurred on March 30, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 5,761 shares of common stock, as shown in Table I. The remaining 5,762 restricted stock units are shown in Table II, which are scheduled to vest on March 31, 2019.

F1 · derivative.exercise_date: On March 31, 2016, the reporting person received a grant of 17,284 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 31, 2017, resulting in the vesting and settlement of 5,761 shares of common stock. The second vesting date occurred on March 30, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 5,761 shares of common stock, as shown in Table I. The remaining 5,762 restricted stock units are shown in Table II, which are scheduled to vest on March 31, 2019.

F1 · derivative.expiration_date: On March 31, 2016, the reporting person received a grant of 17,284 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 31, 2017, resulting in the vesting and settlement of 5,761 shares of common stock. The second vesting date occurred on March 30, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 5,761 shares of common stock, as shown in Table I. The remaining 5,762 restricted stock units are shown in Table II, which are scheduled to vest on March 31, 2019.

F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 21:30 UTC
Evans Jason EricPres. of Hospital Operations
Tax withholdingCommon Stock 2,267 $24.25 $54,974.75
Disclosure

SEC source: 0001209191-18-022531 · doc4.xml · nonDerivative · entry 2

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,809

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 21:30 UTC
Evans Jason EricPres. of Hospital Operations
Exercise / conversionCommon Stock 5,761 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-022531 · doc4.xml · nonDerivative · entry 1

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,076

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On March 31, 2016, the reporting person received a grant of 17,284 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 31, 2017, resulting in the vesting and settlement of 5,761 shares of common stock. The second vesting date occurred on March 30, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 5,761 shares of common stock, as shown in Table I. The remaining 5,762 restricted stock units are shown in Table II, which are scheduled to vest on March 31, 2019.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 22:24 UTC
PITTS KEITH BVice Chairman
Exercise / conversion2016 March Restricted Stock Units · Derivative 20,392 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-019393 · doc4.xml · derivative · entry 3

PITTS KEITH B · CIK 0001055066 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,393

Underlying: Common Stock · 20,392 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As previously reported, on March 10, 2016, the reporting person received a grant of 61,177 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 20,392 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 20,392 shares of common stock, as shown in Table I. The remaining 20,393 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F1 · derivative.exercise_date: As previously reported, on March 10, 2016, the reporting person received a grant of 61,177 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 20,392 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 20,392 shares of common stock, as shown in Table I. The remaining 20,393 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F1 · derivative.expiration_date: As previously reported, on March 10, 2016, the reporting person received a grant of 61,177 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 20,392 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 20,392 shares of common stock, as shown in Table I. The remaining 20,393 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 22:24 UTC
PITTS KEITH BVice Chairman
Tax withholdingCommon Stock 8,025 $24.18 $194,044.50
Disclosure

SEC source: 0001209191-18-019393 · doc4.xml · nonDerivative · entry 2

PITTS KEITH B · CIK 0001055066 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,524

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 22:24 UTC
PITTS KEITH BVice Chairman
Exercise / conversionCommon Stock 20,392 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-019393 · doc4.xml · nonDerivative · entry 1

PITTS KEITH B · CIK 0001055066 · Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously reported, on March 10, 2016, the reporting person received a grant of 61,177 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 20,392 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 20,392 shares of common stock, as shown in Table I. The remaining 20,393 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 22:22 UTC
Evans Jason EricPres. of Hospital Operations
Exercise / conversion2016 March Restricted Stock Units · Derivative 2,615 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-019391 · doc4.xml · derivative · entry 3

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,615

Underlying: Common Stock · 2,615 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As previously reported, on March 10, 2016, the reporting person received a grant of 7,844 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 2,614 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 2,615 shares of common stock, as shown in Table I. The remaining 2,615 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F1 · derivative.exercise_date: As previously reported, on March 10, 2016, the reporting person received a grant of 7,844 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 2,614 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 2,615 shares of common stock, as shown in Table I. The remaining 2,615 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F1 · derivative.expiration_date: As previously reported, on March 10, 2016, the reporting person received a grant of 7,844 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 2,614 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 2,615 shares of common stock, as shown in Table I. The remaining 2,615 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 22:22 UTC
Evans Jason EricPres. of Hospital Operations
Tax withholdingCommon Stock 637 $24.18 $15,402.66
Disclosure

SEC source: 0001209191-18-019391 · doc4.xml · nonDerivative · entry 2

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,315

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 22:22 UTC
Evans Jason EricPres. of Hospital Operations
Exercise / conversionCommon Stock 2,615 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-019391 · doc4.xml · nonDerivative · entry 1

Evans Jason Eric · CIK 0001670094 · Pres. of Hospital Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously reported, on March 10, 2016, the reporting person received a grant of 7,844 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 2,614 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 2,615 shares of common stock, as shown in Table I. The remaining 2,615 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 22:20 UTC
Cancelmi Daniel JChief Financial Officer
Exercise / conversion2016 March Restricted Stock Units · Derivative 12,026 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-019388 · doc4.xml · derivative · entry 3

Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,027

Underlying: Common Stock · 12,026 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As previously reported, on March 10, 2016, the reporting person received a grant of 36,079 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 12,026 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 12,026 shares of common stock, as shown in Table I. The remaining 12,027 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F1 · derivative.exercise_date: As previously reported, on March 10, 2016, the reporting person received a grant of 36,079 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 12,026 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 12,026 shares of common stock, as shown in Table I. The remaining 12,027 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F1 · derivative.expiration_date: As previously reported, on March 10, 2016, the reporting person received a grant of 36,079 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 12,026 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 12,026 shares of common stock, as shown in Table I. The remaining 12,027 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 22:20 UTC
Cancelmi Daniel JChief Financial Officer
Tax withholdingCommon Stock 4,733 $24.18 $114,443.94
Disclosure

SEC source: 0001209191-18-019388 · doc4.xml · nonDerivative · entry 2

Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,049

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Read SEC document
March 09, 2018 Filed Mar 13, 2018 22:20 UTC
Cancelmi Daniel JChief Financial Officer
Exercise / conversionCommon Stock 12,026 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-019388 · doc4.xml · nonDerivative · entry 1

Cancelmi Daniel J · CIK 0001396106 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: As previously reported, on March 10, 2016, the reporting person received a grant of 36,079 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on March 10, 2017, resulting in the vesting and settlement of 12,026 shares of common stock. The second vesting date occurred on March 9, 2018 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 12,026 shares of common stock, as shown in Table I. The remaining 12,027 restricted stock units are shown in Table II, which are scheduled to vest on March 10, 2019.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.